|
Volumn 11, Issue 10, 2000, Pages 659-665
|
Epoetin alfa therapy for anaemia in HIV-infected patients: Impact on quality of life
a b c |
Author keywords
Anaemia; Epoetin alfa; Human immunodeficiency virus (HIV); Quality of life
|
Indexed keywords
ACICLOVIR;
ANABOLIC AGENT;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIRETROVIRUS AGENT;
CLARITHROMYCIN;
COTRIMOXAZOLE;
DAPSONE;
DIDANOSINE;
FLUCONAZOLE;
GANCICLOVIR;
INDINAVIR;
ITRACONAZOLE;
KETOCONAZOLE;
LAMIVUDINE;
MEGESTROL;
NANDROLONE;
PENTAMIDINE;
RECOMBINANT ERYTHROPOIETIN;
RIFABUTIN;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
STEROID;
TESTOSTERONE;
UNINDEXED DRUG;
ZALCITABINE;
ZIDOVUDINE;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
CLINICAL TRIAL;
DRUG EFFECT;
HEMOGLOBIN DETERMINATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
OPPORTUNISTIC INFECTION;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
TREATMENT OUTCOME;
VIRUS INFECTION;
ADULT;
ANEMIA;
EPOETIN ALFA;
FEMALE;
HEMATINICS;
HEMOGLOBINS;
HIV INFECTIONS;
HUMANS;
MALE;
QUALITY OF LIFE;
|
EID: 0033792871
PISSN: 09564624
EISSN: None
Source Type: Journal
DOI: 10.1258/0956462001915020 Document Type: Article |
Times cited : (70)
|
References (19)
|